280 related articles for article (PubMed ID: 1853202)
21. Structural determinants of the Alzheimer's amyloid beta-peptide.
Soto C; Brañes MC; Alvarez J; Inestrosa NC
J Neurochem; 1994 Oct; 63(4):1191-8. PubMed ID: 7931272
[TBL] [Abstract][Full Text] [Related]
22. Reversible random coil-beta-sheet transition of the Alzheimer beta-amyloid fragment (25-35).
Terzi E; Hölzemann G; Seelig J
Biochemistry; 1994 Feb; 33(6):1345-50. PubMed ID: 8312252
[TBL] [Abstract][Full Text] [Related]
23. Kinetics of aggregation of synthetic beta-amyloid peptide.
Tomski SJ; Murphy RM
Arch Biochem Biophys; 1992 May; 294(2):630-8. PubMed ID: 1567217
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues.
Gordon DJ; Sciarretta KL; Meredith SC
Biochemistry; 2001 Jul; 40(28):8237-45. PubMed ID: 11444969
[TBL] [Abstract][Full Text] [Related]
25. Structural heterogeneity in familial Alzheimer's disease mutants of amyloid-beta peptides.
Chong SH; Yim J; Ham S
Mol Biosyst; 2013 May; 9(5):997-1003. PubMed ID: 23358498
[TBL] [Abstract][Full Text] [Related]
26. Structure determination of extracellular fragments of amyloid proteins involved in Alzheimer's disease and Dutch-type hereditary cerebral haemorrhage with amyloidosis.
Sorimachi K; Craik DJ
Eur J Biochem; 1994 Jan; 219(1-2):237-51. PubMed ID: 8306991
[TBL] [Abstract][Full Text] [Related]
27. Solution structure of humanin, a peptide against Alzheimer's disease-related neurotoxicity.
Benaki D; Zikos C; Evangelou A; Livaniou E; Vlassi M; Mikros E; Pelecanou M
Biochem Biophys Res Commun; 2005 Apr; 329(1):152-60. PubMed ID: 15721287
[TBL] [Abstract][Full Text] [Related]
28. NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, A beta(1-40)(ox) and A beta(1-42)(ox).
Riek R; Güntert P; Döbeli H; Wipf B; Wüthrich K
Eur J Biochem; 2001 Nov; 268(22):5930-6. PubMed ID: 11722581
[TBL] [Abstract][Full Text] [Related]
29. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides.
Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
J Mol Biol; 1992 Nov; 228(2):460-73. PubMed ID: 1453457
[TBL] [Abstract][Full Text] [Related]
30. Influence of end-capping on the self-assembly of model amyloid peptide fragments.
Castelletto V; Hamley IW; Cenker Ç; Olsson U; Adamcik J; Mezzenga R; Miravet JF; Escuder B; Rodríguez-Llansola F
J Phys Chem B; 2011 Mar; 115(9):2107-16. PubMed ID: 21309578
[TBL] [Abstract][Full Text] [Related]
31. Conformations of synthetic beta peptides in solid state and in aqueous solution: relation to toxicity in PC12 cells.
Buchet R; Tavitian E; Ristig D; Swoboda R; Stauss U; Gremlich HU; de La Fournière L; Staufenbiel M; Frey P; Lowe DA
Biochim Biophys Acta; 1996 Jan; 1315(1):40-6. PubMed ID: 8611645
[TBL] [Abstract][Full Text] [Related]
32. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.
Roher AE; Lowenson JD; Clarke S; Wolkow C; Wang R; Cotter RJ; Reardon IM; Zürcher-Neely HA; Heinrikson RL; Ball MJ
J Biol Chem; 1993 Feb; 268(5):3072-83. PubMed ID: 8428986
[TBL] [Abstract][Full Text] [Related]
33. The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysis.
Soto C; Castaño EM
Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):701-7. PubMed ID: 8670088
[TBL] [Abstract][Full Text] [Related]
34. The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation.
Soto C; Castaño EM; Frangione B; Inestrosa NC
J Biol Chem; 1995 Feb; 270(7):3063-7. PubMed ID: 7852387
[TBL] [Abstract][Full Text] [Related]
35. Are beta-sheet breaker peptides dissolving the therapeutic problem of Alzheimer's disease?
Permanne B; Adessi C; Fraga S; Frossard MJ; Saborio GP; Soto C
J Neural Transm Suppl; 2002; (62):293-301. PubMed ID: 12456072
[TBL] [Abstract][Full Text] [Related]
36. Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease.
Sticht H; Bayer P; Willbold D; Dames S; Hilbich C; Beyreuther K; Frank RW; Rösch P
Eur J Biochem; 1995 Oct; 233(1):293-8. PubMed ID: 7588758
[TBL] [Abstract][Full Text] [Related]
37. High helical propensity of the peptide fragments derived from beta-lactoglobulin, a predominantly beta-sheet protein.
Hamada D; Kuroda Y; Tanaka T; Goto Y
J Mol Biol; 1995 Dec; 254(4):737-46. PubMed ID: 7500346
[TBL] [Abstract][Full Text] [Related]
38. Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic beta-protein fragments.
Halverson K; Fraser PE; Kirschner DA; Lansbury PT
Biochemistry; 1990 Mar; 29(11):2639-44. PubMed ID: 2346740
[TBL] [Abstract][Full Text] [Related]
39. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide.
Cottingham MG; Hollinshead MS; Vaux DJ
Biochemistry; 2002 Nov; 41(46):13539-47. PubMed ID: 12427014
[TBL] [Abstract][Full Text] [Related]
40. Amide solvent protection analysis demonstrates that amyloid-beta(1-40) and amyloid-beta(1-42) form different fibrillar structures under identical conditions.
Olofsson A; Lindhagen-Persson M; Sauer-Eriksson AE; Ohman A
Biochem J; 2007 May; 404(1):63-70. PubMed ID: 17280549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
